04:29 PM EST, 03/05/2024 (MT Newswires) -- Richard Daniell, Executive Vice President, European Commercial, on March 03, 2024, sold 95,762 shares in Teva Pharmaceutical Industries ( TEVA ) for $1,277,207. Following the Form 4 filing with the SEC, Daniell has control over a total of 69,770 shares of the company, with 69,770 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/818686/000095017024025982/xslF345X03/ownership.xml